Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
基本信息
- 批准号:8651860
- 负责人:
- 金额:$ 39.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-15 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAntibodiesAntibody FormationAntigen-Antibody ComplexAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmune ResponsesB cell differentiationB-LymphocytesBindingBiologicalBiological AssayBlocking AntibodiesBone MarrowCell Differentiation processCell physiologyCellsCuesDNA BindingDNA Binding DomainDNA SequenceDataDefectDevelopmentEnhancersExhibitsGene ExpressionGene TargetingGenesGleanHematopoieticHomeostasisImmune responseImmunoglobulin GImmunoglobulin MImmunoglobulin-Secreting CellsIn VitroInfectionKidney DiseasesKnockout MiceLigandsModelingMolecularMolecular ProfilingMusNuclear AntigensNucleic Acid Regulatory SequencesOrganPathologyPathway interactionsPeripheralPlasma CellsPreventionProcessProductionProteinsReceptor SignalingRegulationRelative (related person)Rheumatoid FactorRoleSerumSignal TransductionT-LymphocyteTLR7 geneTissuesToll-like receptorsTranscriptional RegulationTransgenic MiceTransgenic ModelTransgenic Organismsanergyautoreactive B cellcell typecohortdifferentiated B cellfightingin vitro Assayin vivoinhibiting antibodyinsightmouse modelnovelpathogenpreventpromoterpublic health relevanceresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): The production of antibodies by antibody-secreting cells (ASCs) is critically important for immune responses to many different pathogens. However, in autoimmune diseases where B cell tolerance is broken, many ASCs secrete autoantibodies and contribute in a major way to organ pathology. The differentiation of B cells into ASCs is controlled by a cohort of key transcription factors including Ets-1, which serves as a negative regulator of this process. In the absence of Ets-1, B cells undergo enhanced differentiation into ASCs many of which secrete autoantibodies as demonstrated by high titers of IgM and IgG autoantibodies in the serum. Recently Toll- like receptor (TLR) signaling, particularly via TLR7 and TLR9, has been implicated in the activation of autoreactive B cells to differentiate into ASCs. Interestingly, Ets-1 deficient B cells exhibit enhanced responses to TLR7 and TLR9 ligands in vitro and Ets-1 knockout mice lacking the TLR adaptor protein Myd88 have reduced autoantibody production. Toll-like receptor signaling is a potent inducer of the expression of Blimp-1, a key transcription factor that drives ASC differentiation. Ets-1 physically interacts with Blimp-1 to inhibit the ability of Blimp-1 to bind target DNA sequences. In contrast, a closely related transcription factor Ets-2 is unable to block Blimp-1 binding or to inhibit ASC differentiation. Ets-1 also is thought to regulate the expression of critical target genes controlling ASC formation, but the identity of most of these targets remains unclear. In this application we propose a variety of assays to further define the role of Ets-1 in regulating target gene expression, Blimp-1 activity and ASC differentiation. These studies will be aided by comparing biological activities of Ets-1, which can block ASC differentiation, with the closely related Ets-2 protein, which lacks this activity. The specific aims of the proposal are (1) to determine which cell types require Ets-1 activity to limit ASC formation, autoantibody secretion and autoimmune disease, (2) to examine the in vivo role of TLR7 and 9 ligands in activating Ets-1 deficient B cells, (3) to identify Ets-1 dependent gene expression pathways regulating ASC formation and (4) to identify structural features of Ets-1 that impart a unique ability to regulate ASC development. Together our studies will provide novel insights into the transcriptional regulation of B cell differentiation particularly in situations of autoantibody secretion.
描述(由申请人提供):通过抗体分泌细胞(ASC)生产抗体对于对许多不同病原体的免疫反应至关重要。但是,在B细胞耐受性破坏的自身免疫性疾病中,许多ASC分泌自身抗体,并以主要方式进行器官病理学做出贡献。 B细胞将B细胞分化为ASC,由包括ETS-1在内的一系列关键转录因子控制,这是该过程的负调节剂。在没有ETS-1的情况下,B细胞会增强分化为ASC,其中许多分泌自身抗体,如血清中IgM和IgG自身抗体的高滴度所证明的那样。最近,Toll-Like受体(TLR)信号传导,特别是通过TLR7和TLR9,与自动反应性B细胞的激活有关,以分化为ASC。有趣的是,ETS-1缺乏的B细胞在体外表现出对TLR7和TLR9配体的反应增强,而缺乏TLR适配器蛋白MYD88的ETS-1基因敲除小鼠的自身抗体产生降低。 Toll样受体信号传导是Blimp-1表达的有效诱导剂,Blimp-1是驱动ASC分化的关键转录因子。 ETS-1与Blimp-1物理相互作用,以抑制Blimp-1结合靶DNA序列的能力。相反,密切相关的转录因子ETS-2无法阻止Blimp-1结合或抑制ASC分化。 ETS-1也被认为可以调节控制ASC形成的关键靶基因的表达,但是大多数目标的身份尚不清楚。在此应用中,我们提出了多种测定法,以进一步定义ETS-1在调节靶基因表达,BLIMP-1活性和ASC分化中的作用。这些研究将通过比较ETS-1的生物学活性,从而阻止ASC分化,而Eets-2蛋白质缺乏这种活性。 The specific aims of the proposal are (1) to determine which cell types require Ets-1 activity to limit ASC formation, autoantibody secretion and autoimmune disease, (2) to examine the in vivo role of TLR7 and 9 ligands in activating Ets-1 deficient B cells, (3) to identify Ets-1 dependent gene expression pathways regulating ASC formation and (4) to identify structural features of Ets-1 that impart a unique ability to规范ASC的发展。我们的研究将共同提供对B细胞分化的转录调节的新见解,尤其是在自身抗体分泌的情况下。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
- DOI:10.4049/jimmunol.1500165
- 发表时间:2015-09-01
- 期刊:
- 影响因子:0
- 作者:Mayeux J;Skaug B;Luo W;Russell LM;John S;Saelee P;Abbasi H;Li QZ;Garrett-Sinha LA;Satterthwaite AB
- 通讯作者:Satterthwaite AB
Genome-Wide Identification of Target Genes for the Key B Cell Transcription Factor Ets1.
- DOI:10.3389/fimmu.2017.00383
- 发表时间:2017
- 期刊:
- 影响因子:7.3
- 作者:Saelee P;Kearly A;Nutt SL;Garrett-Sinha LA
- 通讯作者:Garrett-Sinha LA
Bacterial infections in lupus: Roles in promoting immune activation and in pathogenesis of the disease.
- DOI:10.1016/j.jtauto.2020.100078
- 发表时间:2021
- 期刊:
- 影响因子:3.9
- 作者:Battaglia M;Garrett-Sinha LA
- 通讯作者:Garrett-Sinha LA
Review of Ets1 structure, function, and roles in immunity.
- DOI:10.1007/s00018-012-1243-7
- 发表时间:2013-09
- 期刊:
- 影响因子:8
- 作者:Garrett-Sinha, Lee Ann
- 通讯作者:Garrett-Sinha, Lee Ann
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEE ANN Garrett-Sinha其他文献
LEE ANN Garrett-Sinha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEE ANN Garrett-Sinha', 18)}}的其他基金
Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome
探索转录因子 Ets1 在干燥综合征中的作用
- 批准号:
10644080 - 财政年份:2023
- 资助金额:
$ 39.3万 - 项目类别:
Regulation and Consequences of Ets1 Downregulation in B Cells
B 细胞中 Ets1 下调的调控和后果
- 批准号:
9896768 - 财政年份:2016
- 资助金额:
$ 39.3万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8259852 - 财政年份:2010
- 资助金额:
$ 39.3万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8070010 - 财政年份:2010
- 资助金额:
$ 39.3万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8461248 - 财政年份:2010
- 资助金额:
$ 39.3万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8516184 - 财政年份:2010
- 资助金额:
$ 39.3万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
7984141 - 财政年份:2010
- 资助金额:
$ 39.3万 - 项目类别:
Identification of Specific Roles for Ets-1 in B Cell Tolerance
鉴定 Ets-1 在 B 细胞耐受中的具体作用
- 批准号:
8264121 - 财政年份:2010
- 资助金额:
$ 39.3万 - 项目类别:
Ets-1 Expression in Squamous Cells of the Oral Cavity
口腔鳞状细胞中 Ets-1 的表达
- 批准号:
7257725 - 财政年份:2007
- 资助金额:
$ 39.3万 - 项目类别:
Ets-1 Expression in Squamous Cells of the Oral Cavity
Ets-1 在口腔鳞状细胞中的表达
- 批准号:
7413995 - 财政年份:2007
- 资助金额:
$ 39.3万 - 项目类别:
相似国自然基金
募集HBV抗体用于肿瘤免疫治疗的分子设计及作用机制
- 批准号:22377041
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
双特异性抗体囊泡对胞内细菌感染的免疫综合机制研究
- 批准号:82304366
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
四种停用喹诺酮类药物高分辨力单克隆抗体的精准制备及其识别机制研究
- 批准号:32373059
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DHEA协同别构纳米抗体通过ADGRG2调控男性生殖功能障碍的作用及机制
- 批准号:82371629
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus
系统性红斑狼疮 DNA 特异性自身免疫机制
- 批准号:
10374852 - 财政年份:2018
- 资助金额:
$ 39.3万 - 项目类别:
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS
肌动蛋白调节蛋白对适应性免疫的控制
- 批准号:
8824481 - 财政年份:2014
- 资助金额:
$ 39.3万 - 项目类别:
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS
肌动蛋白调节蛋白对适应性免疫的控制
- 批准号:
9035349 - 财政年份:2014
- 资助金额:
$ 39.3万 - 项目类别:
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS
肌动蛋白调节蛋白对适应性免疫的控制
- 批准号:
8694684 - 财政年份:2014
- 资助金额:
$ 39.3万 - 项目类别: